Chantix Settlement
Pfizer settled allegations that it sold the smoking-cessation drug Chantix that was allegedly affected by the issues described in the litigation. Pfizer denies any wrongdoing and the court made no finding of liability.
A settlement for people who bought Chantix in the United States between September 29, 2015 and September 17, 2021. Consumers who file a claim share the settlement fund, paid on a pro rata basis according to how much they paid.
- Estimated payment
- pro rata share of the fundTotal fund: $44,000,000.00
- Claim deadline
- Who is eligible
- Consumers who purchased Chantix in the United States and its Territories from September 29, 2015 through September 17, 2021.
- How you get paid
- Consumers who submit a Claim Form receive a pro rata share based on the amount they paid for Chantix, capped at 20% of the Available Settlement Fund. Payments depend on the number and size of valid claims.
- Proof required
- Proof of purchase supports a claim. The Claim Form explains what is accepted; you can submit it online or by mail.
This information is not a substitute for legal advice.
Verified on . Based on Official Settlement Website — Chantix Class Action Settlement (United States District Court for the Southern District of New York) (A.B. Data, 2026). See the method.